N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research

Expert Opinion on Investigational Drugs
Kirsten C MorleyPaul S Haber

Abstract

Alcoholic liver disease (ALD) is the leading cause of alcohol-related death and one of the most common forms of liver disease. Abstinence from alcohol is crucial to reducing morbidity and mortality associated with the disease. However, there are few pharmacotherapies for alcohol use disorder suitable for those with significant liver disease. This paper presents a rationale for investigating the use of N-acetyl cysteine (NAC) to promote abstinence or reduce heavy alcohol consumption for patients with an alcohol use disorder, particularly in the presence of liver disease. NAC is an antioxidant with glutamatergic modulating and anti-inflammatory properties. Evidence is emerging that oxidative stress, neuro-inflammation and dysregulation of glutamatergic neurotransmission play a key role in alcohol use disorder. Similarly, oxidative stress is known to contribute to ALD. We outline the studies that have investigated NAC to reduce alcohol consumption including preclinical and clinical studies. We also review the evidence for NAC in other addictions as well as psychiatric and physical comorbidities associated with alcohol use disorders. NAC is low cost, well-tolerated and could have promise for the treatment of alcohol use disorder in...Continue Reading

References

Jan 1, 1984·Journal of Studies on Alcohol·R E Tarter, A I Alterman
Nov 12, 1983·British Medical Journal·I Ewusi-MensahR Williams
Oct 1, 1994·Alcoholism, Clinical and Experimental Research·B J MasonE Mantero-Atienza
Jun 5, 2003·Nature Neuroscience·David A BakerPeter W Kalivas
Dec 17, 2003·Journal of Gastroenterology and Hepatology·Paul S HaberGeoffrey W McCaughan
Feb 16, 2006·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Maria KellyPaul S Haber
Jul 4, 2007·The American Journal of Psychiatry·Steven D LaRoweRobert Malcolm
Jun 17, 2009·The Australian and New Zealand Journal of Psychiatry·Maree TeessonKatherine Mills
Sep 1, 2009·Biological Psychiatry·Lori A KnackstedtPeter W Kalivas
Mar 23, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Youssef SariRichard L Bell
Jul 9, 2011·Journal of Orthopaedic Trauma·Dustin L VolkmerJohn J Callaci
Sep 6, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·G M DoreN Latt
Nov 11, 2011·The New England Journal of Medicine·Eric Nguyen-KhacUNKNOWN AAH-NAC Study Group
May 3, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lianne SchmaalAnna E Goudriaan
Jun 19, 2012·The American Journal of Psychiatry·Kevin M GrayKathleen T Brady
Feb 14, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jochen BauerPatricia Ohrmann
Mar 5, 2013·CNS Drugs·Giovanni AddoloratoRaffaele Landolfi
Mar 21, 2013·Journal of Hepatology·Jürgen RehmKevin D Shield
Oct 31, 2013·Alcohol·Samantha M SimetJoseph H Sisson
Jan 5, 2014·Mediators of Inflammation·Hideto KawarataniHiroshi Fukui
Mar 13, 2014·Addiction Biology·Kathryn J ReissnerPeter W Kalivas
May 16, 2014·JAMA : the Journal of the American Medical Association·Daniel E JonasJames C Garbutt
Aug 1, 2014·Frontiers in Psychiatry·Florent BernardinFrançois Paille
Oct 14, 2014·Handbook of Clinical Neurology·Greg T SutherlandJillian J Kril
Mar 3, 2015·Redox Report : Communications in Free Radical Research·Eduardo PradoSandra Odebrecht Vargas Nunes
Jun 4, 2015·The Journal of Clinical Psychiatry·Astrid WaterdrinkerOlivia M Dean
Jun 23, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Benjamin RollandOlivier Cottencin
Aug 4, 2015·Journal of Affective Disorders·Daniel F HermensJim Lagopoulos
Aug 11, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Anam KhanFasiha Kanwal
Oct 10, 2015·Psychopharmacology·Jacqueline M BarkerL Judson Chandler
Dec 10, 2015·Australian Prescriber·Mike McDonough
Feb 9, 2016·Multidisciplinary Respiratory Medicine·Claudio M Sanguinetti

❮ Previous
Next ❯

Citations

Apr 6, 2019·World Journal of Gastroenterology : WJG·Wen-Jun WangYan-Hang Gao
Oct 17, 2020·Journal of Neuroscience Research·María José Cano-CebriánTeodoro Zornoza
Feb 23, 2021·Expert Opinion on Pharmacotherapy·Kirsten C MorleyPaul Haber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Alcohol Use Disorder

Alcohol use disorder involves a pattern of alcohol consumption that includes compulsive use and a loss of control over intake of alcohol. The impact on physical health, socioeconomic factors, and psychiatric health is profound. Find the latest research on alcohol use disorder here.

Related Papers

Acta Medica Scandinavica. Supplementum
G A Martini, R Teschke
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries
R L BerkelmanM Dufour
Expert Opinion on Investigational Drugs
Thomas HillemacherAnnemarie Heberlein
© 2022 Meta ULC. All rights reserved